| API | active pharmaceutical ingredient |
| ATMP | advanced therapy medicinal product |
| BCA | bicinchoninic acid assay |
| BPyV | bovine polyomavirus |
| BSA | bovine serum albumin |
| CD | cluster of differentiation |
| CHUV | Centre hospitalier universitaire Vaudois |
| CPP | critical process parameter |
| CQA | critical quality attribute |
| DMEM | Dulbecco’s modified Eagle medium |
| DMSO | dimethyl sulfoxide |
| DNA | deoxyribonucleic acid |
| EBV | Epstein-Barr virus |
| EC | European Commission |
| ECACC | European collection of authenticated cell cultures |
| EDQM | European Directorate for the Quality of Medicines & Healthcare |
| EDTA | ethylenediaminetetraacetic acid |
| ELISA | enzyme-linked immunosorbent assay |
| EOPCB | end of production cell bank |
| EP | European Pharmacopoeia |
| ESC | embryonic stem cells |
| FACS | fluorescence activated cell-sorting |
| FBS | fetal bovine serum |
| FDA | US Food and Drug Administration |
| FPC | fibroblast progenitor cells |
| FT | freeze-thaw |
| GMP | good manufacturing practices |
| HAV | hepatitis A virus |
| HBV | hepatitis B virus |
| HBoV | human bocavirus |
| hCMV | human cytomegalovirus |
| HCV | hepatitis C virus |
| HHV | human herpes virus |
| HIV | human immunodeficiency virus |
| HPV | human papilloma virus |
| HTLV | human T-cell lymphotropic virus |
| IPC | in-process control |
| KIPyV | KI polyomavirus |
| KPP | key process parameter |
| LYO | lyophilizate |
| MCB | master cell bank |
| MoA | mechanism of action |
| MSC | mesenchymal stem cells |
| PBB | Progenitor Biological Bandage |
| PBS | phosphate-buffered saline |
| PCB | parental cell bank |
| PDT | population doubling time |
| PDV | population doubling value |
| PPC | post-process control |
| RH | relative humidity |
| SD | standard deviation |
| SV40 | simian virus 40 |
| TEM | transmission electron microscopy |
| TEP | tissue engineering product |
| TrSt | standardized transplant product |
| USA | United States of America |
| WCB | working cell bank |
| WUPyV | WU polyomavirus |